Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Amphotericin B and Its New Derivatives – Mode of Action

Author(s): M. Baginski and J. Czub

Volume 10, Issue 5, 2009

Page: [459 - 469] Pages: 11

DOI: 10.2174/138920009788898019

Price: $65

Abstract

Amphotericin B (AmB) is a well known antifungal and antiprotozoal antibiotic used in the clinic for several decades. Clinical applications of AmB, however, are limited by its nephrotoxicity and many other acute side effects which are not acceptable by patients when their life is not threaten. In order to improve the therapeutic index of this drug, lipid formulations have been introduced and many efforts have been made to obtain less toxic AmB derivatives by chemical modifications of the parent drug. This review presents concise knowledge about this fascinating compound and a critical review of the data published within last few years about the mechanism of action of this antibiotic. In particular, in the present work we discuss: i) structure and properties of AmB and its recently synthesized new derivatives; ii) antifungal and antileishmanial activity and toxicity of these compounds; and iii) mode of action of AmB and its derivatives at cellular and molecular levels, with particular attention paid to interactions of AmB and different components of cellular membranes.

Keywords: Amphotericin B, Amphotericin B derivatives, antifungal activity, antileishmanial activity, lipid membranes, sterols, mechanism of action


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy